We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
193 hedge funds and large institutions have $644M invested in Revance Therapeutics, Inc. in 2023 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 74 increasing their positions, 49 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
242% more call options, than puts
Call options by funds: $18M | Put options by funds: $5.27M
51% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 49
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
4% more funds holding
Funds holding: 186 → 193 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
28% less capital invested
Capital invested by funds: $893M → $644M (-$249M)
Holders
193
Holders Change
+7
Holders Change %
+3.76%
% of All Funds
2.81%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
74
Reduced
49
Closed
32
Calls
$18M
Puts
$5.27M
Net Calls
+$12.7M
Net Calls Change
+$9.27M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$9.47M |
| 2 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
+$6.72M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$5.83M |
| 4 |
BlackRock
New York
|
+$5.71M |
| 5 |
Walleye Capital
New York
|
+$5.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.5M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.2M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$10.6M |
| 4 |
DM
Deerfield Management
New York
|
-$9.98M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$8.19M |
